Study Summary
This trial will study the safety & effectiveness of IW-3300 for treating IC/BPS symptoms like bladder pain, burning, pressure, & discomfort. Subjects will get either the drug or placebo.
- Interstitial Cystitis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 6 Secondary · Reporting Duration: Baseline, Week 12
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
IW-3300 100 µg
1 of 3
IW-3300 300 µg
1 of 3
Placebo
1 of 3
Experimental Treatment
Non-Treatment Group
300 Total Participants · 3 Treatment Groups
Primary Treatment: IW-3300 100 µg · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 70 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is there any capacity for new enrollees in this experiment?
"As verified by clinicaltrials.gov, this medical trial opened for patient recruitment on March 1st 2023 and was last updated a couple days ago." - Anonymous Online Contributor
Am I eligible to take part in this research project?
"This clinical trial is seeking 300 individuals with interstitial cystitis, aged between 18 to 70 years of age." - Anonymous Online Contributor
Has IW-3300 100 µg achieved regulatory approval from the FDA?
"As this is a Phase 2 trial with some evidence supporting its safety, our evaluation placed IW-3300 100 µg at a score of two. However, efficacy data has yet to be established for this drug." - Anonymous Online Contributor
Are there any age restrictions for those wishing to participate in the trial?
"The age eligibility range for this trial is 18 to 70. For those younger than 18, there are 383 other trials available; and similarly, 1011 studies can be found for those over 65 years of age." - Anonymous Online Contributor
How many subjects are enrolled in this investigation?
"Yes, according to the data hosted on clinicaltrials.gov, this medical trial is actively searching for volunteers. It was initially posted on March 1st of 2023 and subsequently updated most recently on March 3rd of that same year. The research team needs 300 patients from 2 separate sites in order to meet their enrollment goals." - Anonymous Online Contributor